News & Updates
Showing Oncology articles
Showing
Show Multimedia Only

Adjuvant palbociclib + ET does not improve outcomes vs ET alone in early breast cancer
15 Dec 2021
byChristina Lau
Adjuvant palbociclib in combination with endocrine therapy (ET) does not improve invasive disease-free survival (iDFS) or secondary endpoints vs ET alone in patients with hormone receptor–positive, HER2-negative early breast cancer, final results of the phase III PALLAS trial have shown.
15 Dec 2021

Cutting first-day dexamethasone dose not recommended for breast cancer patients on anthracycline
11 Dec 2021
In breast cancer patients treated with anthracycline-containing regimens, reducing the first-day dose of dexamethasone does not yield significant gastrointestinal benefit and is not recommended for nausea management, a recent study has found.
11 Dec 2021






